Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area metabolism cyp3a cyp450'

Search results for: 'research area metabolism cyp3a cyp450'

Items 1-10 of 126

Page
per page
  1. Clarithromycin
    A4322 Clarithromycin
    Target: Cytochrome P450 (CYP450)
    Summary: CYP3A inhibitor, potent
      ≥31.2 mg/mL
  2. Cobicistat (GS-9350)
    A4313 Cobicistat (GS-9350)
    Target: Cytochrome P450 (CYP450)
    Summary: Selective CYP3A inhibitor
      insoluble in H2O; ≥150.9 mg/mL
  3. Cilomilast
    A4329 Cilomilast
    Target: Phosphodiesterases (PDEs)
    Summary: Potent PDE4 inhibitor
      insoluble in H2O; ≥12.95 mg/mL
  4. NLG919
    A4373 NLG919
     1 Citation
    Summary: Potent IDO pathway inhibitor
      insoluble in H2O; insoluble in EtOH; ≥47.7 mg/mL
  5. Levomefolate calcium
    A3552 Levomefolate calcium
    Summary: Artificial form of folate
      insoluble in EtOH; insoluble in DMSO; insoluble in H2O
  6. GW9662
    A4300 GW9662
     1 Citation
    Summary: PPARγ antagonist
      insoluble in H2O; ≥13.75 mg/mL
  7. T0070907
    A4301 T0070907
    Summary: Human PPARγ antagonist,potent and selective
      ≥27.8 mg/mL
  8. Ciprofibrate
    A4306 Ciprofibrate
    Summary: PPARα agonist
      insoluble in H2O; ≥10.85 mg/mL
  9. Alizarin
    A4308 Alizarin
    Summary: Chelator for calcium,used to stain calcium deposites,Alizarin complexone is used for bone staining to study bone remodeling
      insoluble in EtOH; insoluble in H2O; ≥8.12 mg/mL
  10. GW501516
    A4309 GW501516
     1 Citation
    Summary: PPARδ agonist,selective and potent
      insoluble in H2O; ≥18.05 mg/mL

Items 1-10 of 126

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
Clear All
Shopping Options
Category
  1. Proteases 1 item
  2. Apoptosis 1 item
  3. Metabolism 96item
  4. Tyrosine Kinase 1 item
  5. DNA Damage/DNA Repair 2item
  6. PI3K/Akt/mTOR Signaling 2item
  7. Microbiology & Virology 2item
  8. GPCR/G protein 3item
  9. Stem Cell 1 item
  10. Membrane Transporter/Ion Channel 3item
  11. Cancer Biology 1 item
  12. Endocrinology and Hormones 1 item
  13. Neuroscience 3item
  14. Others 9item
  15. Immunology/Inflammation 4item
  16. Vitamin D Related 1 item
Specificity
  1. Selective 44item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 1 item
  2. Irreversible 4item
Target
  1. Acyl coenzyme A: cholesterol acyltransferases 1 item
  2. Factor Xa 1 item
  3. Phosphodiesterases (PDEs) 10item
  4. RARs 1 item
  5. Estrogen and Related Receptors 1 item
  6. Stearoyl-CoA 9-desaturase (SCD-1) 1 item
  7. AMPK 1 item
  8. Cytochrome P450 (CYP450) 4item
  9. Ferroptosis 1 item
  10. HMG-CoA Reductases 3item
  11. SGLT 1 item
  12. DGAT 2item
  13. Insulin and Insulin-like Receptors 1 item
  14. Pyruvate dehydrogenases (PDH) 1 item
  15. CETP 2item
  16. Fatty-acid-binding proteins (FABPs) 1 item
  17. Folate Analogue 1 item
  18. IDH2 1 item
  19. Nampt 1 item
  20. Carbonic Anhydrases 3item
  21. Histamine H1 Receptors 1 item
  22. Phospholipases 1 item
  23. Catechol O-Methyltransferase (COMT) 1 item
  24. Hydroxylases 1 item
  25. ATGL 1 item
  26. FPTase 1 item
  27. PPAR 1 item
  28. FAAH 1 item
  29. carnitine reabsorption 1 item
  30. TRPC channel 1 item
Reported Experiments
  1. Animal Experiments 58item
  2. Cell Experiments 50item
Related Disease
  1. Acne 1 item
  2. Acute Kidney Injury 1 item
  3. Acute Myelogenous Leukemia 1 item
  4. Bladder Cancer 1 item
  5. Bladder Carcinoma 1 item
  6. Brain Injuries Studies 1 item
  7. Breast Cancer 5item
  8. Cancer 14item
  9. Cervical Cancer 1 item
  10. Cocaine-Related Disorders 1 item
  11. Diabetes 1 item
  12. Dyslipidemia 2item
  13. Erectile Dysfunction 3item
  14. HIV 1 item
  15. Hypercholesterolemia 2item
  16. Inflammation 1 item
  17. Inflammatory Diseases 2item
  18. Kidney Injury Studies 1 item
  19. Leukemia 2item
  20. Lung Cancer 2item
  21. Lymphoma 3item
  22. Melanoma 2item
  23. Neuroblastoma 3item
  24. Neurocognitive Disorders 1 item
  25. Obsessive-Compulsive Disorder 1 item
  26. Prostate Cancer 2item
  27. Psoriasis 2item
  28. Psoriasis Vulgaris 1 item
  29. Pulmonary Arterial Hypertension 1 item
  30. Rheumatoid Arthritis 2item
  31. Schizophrenia 2item
  32. Type 2 Diabetes 4item